February 2009

Faculty News

• Cancer specialist new Chief Medical Officer
• Health's chance in a sick economy
• Funding injection for spinal injury research
• Congratulations to our Australia Day Honours recipients

News from the Research Institutes

• The George Institute: New study: lowering blood pressure saves lives in dialysis patients
• The George Institute: Combined treatment reduces kidney disease risk in diabetes
• Centenary Institute: Deciphering the body's healing secrets
• Woolcock Institute’s $10 million refurbishment creates unique facility
• Centenary Institute: $8 million research program to tackle one of Australia’s fastest increasing cancers
• The George Institute: Survey of developing country diseases finds Australia is a major contributor
• The George Institute: Funding for neglected diseases increases to US$ 2.5 billion, but big killer diseases miss out
• Centenary Institute: Cancer rejection - scientists discover crucial molecule

Events

Professor David Sinclair is Professor of Pathology at Harvard Medical School. His biotechnology company Sirtris was recently acquired by Glaxo Smith Kline for $750 million. In 2003, one of his papers was considered a "Discovery of the Year" by Discoverer magazine and in 2006 he was named one of Australia's brightest scientists under 45. More

Look at the Events listing for upcoming events in February and March to see what's going on in the Faculty.